31 October 2017 - - Minnesota, US-based interventional and diagnostic technology company ACIST Medical Systems, Inc. has launched the next generation of its RXI Rapid Exchange FFR system, ACIST RXi Mini System, designed to provide fractional flow reserve measurements to complement angiography, provide qualitative assessment of lesion severity and inform intervention strategy in both diagnosis and treatment of coronary and peripheral artery disease, the company said.
No financial details were disclosed.
ACIST is part of Italy based Bracco Group. As part of the Bracco Group, ACIST benefits from the resources of a multinational conglomerate with broad expertise in cath lab technology and a dedication to continuous advancement.
The RXi mini system is designed to integrate with existing hemodynamic systems and FFR software. The RXi Mini offers flexible mounting configurations, a simple and intuitive user interface, and a small and unobtrusive system profile that adapts to existing workflow and maximises procedural efficiency.
ACIST Medical Systems, Inc. has a portfolio of advanced products, including Rapid Exchange FFR and high definition IVUS systems.
The company offers advanced contrast imaging systems for cardiovascular angiography and radiology imaging. ACIST has over 300 direct employees and facilities in Silicon Valley, Heerlen, and Tokyo.
Bracco Group is active in the healthcare sector through Bracco Imaging (diagnostic imaging), ACIST Medical Systems and HLT (cardiology) and the Centro Diagnostico Italiano diagnostic clinic.
It has around 3,400 employees and annual total consolidated revenues of over EUR 1.3bn. Bracco operates in more than 100 countries worldwide.